Haibei (Laura) Zhao

Welcome! I’m Haibei (Laura) Zhao, a master’s student in the Department of Statistics and Data Science at the University of California, Los Angeles, where I work under the supervision of Yuhua Zhu. I’m also a research assistant at Olin Business School, Washington University in St. Louis, where I work with Arlen Dean on healthcare operations management. Before that, I earned my bachelor’s degree in Management Science at Xiamen University. Before returning to academia, I worked on biotech and healthcare investments in venture capital, followed by data pipelines and analytics in private equity.

My research interests center on healthcare information systems and decision support: how data-driven tools can help healthcare organizations make decisions under uncertainty. My prior work in biotech investing shapes the practical questions I ask, while my training in statistics, reinforcement learning, and optimization shapes how I approach them.

I’m always happy to connect and exchange ideas about research, data, or shared interests.

Research Interests

Research experience

Jun 2026
– Present

Healthcare operations management

[slides]
  • Healthcare

Olin Business School, Washington University in St. Louis

Research Assistant · Advised by Arlen Dean

I study how to schedule follow-up visits for patients receiving treatment for geographic atrophy (GA), an advanced form of dry age-related macular degeneration. At each visit, the return interval affects the timing of the next examination and, if appropriate, the next dose. This makes scheduling a sequence of decisions rather than a fixed calendar choice.

Our work examines how the location of remaining retinal tissue, treatment history, treatment-associated neovascular risk, and visit burden may change the value of returning sooner or later. I am developing a decision model to make these trade-offs explicit and to study how the preferred interval may change as information arrives. The linked slides give a public overview of the clinical setting and research question.

Nov 2025
– Present

Continuous-time reinforcement learning

Department of Statistics and Data Science, University of California, Los Angeles

Research Assistant · Advised by Yuhua Zhu

More research experience
Jun 2026
– Sep 2026

Finance research

Olin Business School, Washington University in St. Louis

Research Assistant · Advised by Nishant Vats

Professional experience

Nov 2022
– Nov 2023

Venture Capital Investment Analyst

  • Healthcare

XMCR Capital

Full-time

Evaluated biotech and healthcare investment opportunities through clinical evidence, market research, and due diligence. For Arthrosi, I developed a risk-adjusted valuation model for its investigational gout drug AR882, incorporating clinical-stage success probabilities and sensitivity analyses to inform the investment decision.

Selected investmentI contributed to XMCR Capital’s 2023 investment in Arthrosi Therapeutics, a biotech company developing gout treatments. In February 2026, Sobi acquired the company in a deal worth up to US$1.5 billion.

More professional experience
Nov 2023
– Apr 2025

Private Equity Investment Analyst

Aladdin Capital

Full-time

Jul 2022
– Oct 2022

Investment Banking Summer Intern

CICC

Internship

Dec 2021
– May 2022

Private Equity Investment Intern

CDH Investments

Internship